Mechanism:Cytarabine is cytotoxic to a wide variety of actively dividing mammalian cells. Acts by interfering with pyrimidine synthesis. It is a potent myelosuppressant and requires careful haematological monitoring during its use. Uses Acute myelocyric leukaemia, acute lymphocytic leukaemia, chronic myeloid leukaemia (blast phase), nonHodgkin's lymphoma in Children:, treatment and maintenance of meningeal neoplasms, erythroleukaemia. Dosage:Adults : 100m m2 1.V. ever 12 hours for 7 da
Vial
134 EGP
Mechanism:Cytarabine is cytotoxic to a wide variety of actively dividing mammalian cells. Acts by interfering with pyrimidine synthesis. It is a potent myelosuppressant and requires careful haematological monitoring during its use. Uses Acute myelocyric leukaemia, acute lymphocytic leukaemia, chronic myeloid leukaemia (blast phase), nonHodgkin's lymphoma in Children:, treatment and maintenance of meningeal neoplasms, erythroleukaemia. Dosage:Adults : 100m m2 1.V. ever 12 hours for 7 da
Note: All the provided information about this drug does not substitute for consulting a doctor.